PATENT CLAIM ANALYSIS

Application Number: 16110682
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "006110"]

Abstract:
The invention provides methods, devices, compositions and kits for diagnosing or predicting transplant status or outcome in a subject who has received a transplant.

Claim (Index 11):
The method of  claim 10 , wherein said immunosuppressant regimen is selected from the group consisting of rapamycin, cyclosporin A, and anti-CD40L monoclonal antibody.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.17391
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16110646', '14188455', '13508318', '14536300', '15319271']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7143893228376369
- 35 USC 102 Novelty (BERT): 0.553234638519422
- Combined Prediction Score: 0.6982738544058155
- Mean Citation Score: 357.328528
- Max Citation Score: 421.71204000000006
- Similarity Product: 288.1336495690084

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test